EMEA-000205-PIP02-11-M06 - paediatric investigation plan
Ceftobiprole medocaril (sodium)
PIPHuman
Key facts
- Invented name
- Zevtera and associated names
- Active Substance
- Ceftobiprole medocaril (sodium)
- Therapeutic area
- Respiratory, thoracic and mediastinal disorders
- Decision number
- P/0027/2024
- PIP number
- EMEA-000205-PIP02-11-M06
- Pharmaceutical form(s)
- Powder for concentrate for solution for infusion
- Condition(s) / indication(s)
- Treatment of pneumonia
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Basilea Pharmaceutica Deutschland GmbH
Email: medical.information@basilea.com
Tel. +41 6160611 11- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date